3 documents found, page 1 of 1
Challenges in the serological evaluation of dogs clinically suspect for canine ...
Santarém, N; Sousa, S; Amorim, CMPG; Carvalho, NL; Carvalho, HL; Felgueiras, Ó; Brito, M; Cordeiro-da-Silva, ACanine leishmaniasis is a major veterinary issue and also a public health challenge due to its zoonotic potential. In this context, serological evaluation is essential for Canine leishmaniasis management. Several serological alternatives, such as rapid diagnostic tests, enzyme-linked immunosorbent assay (ELISA) and immunofluorescence antibody test (IFAT), are well established. In fact, the capacity of distinct ...
Author Correction: Challenges in the serological evaluation of dogs clinically ...
Santarém, N; Sousa, S; Amorim, CMPG; Carvalho, NL; Carvalho, HL; Felgueiras, Ó; Brito, M; Cordeiro-da-Silva, AIn Figure 1C, D, and E the positive and negative controls are missing. The correct Figure 1 appears below.
The Use of Specific Serological Biomarkers to Detect CaniLeish Vaccination in Dogs
Lima, C; Santarém, N; Nieto, J; Moreno, J; Carrillo, E; Bartholomeu, D; Bueno, L; Fujiwara, R; Amorim, CMPG; Cordeiro-da-Silva, ACanine leishmaniosis (CanL) prevention in the Mediterranean basin is considered essential to stop human zoonotic visceral leishmaniasis. In this context, vaccination of dogs is expected to have a significant impact in disease control. CaniLeish® (Virbac Animal Health) is one of a few CanL vaccines that are at this moment licensed in Europe. This vaccine contains purified excreted-secreted proteins of Leishmania...